Alx Oncology Holdings INC (ALXO) — DEF 14A Filings

All DEF 14A filings from Alx Oncology Holdings INC. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.

DEF 14A Filings (2)

ALX Oncology Executive Compensation Details Revealed — Apr 21, 2025 Risk: low
ALX Oncology Holdings Inc. filed a DEF 14A on April 21, 2025, detailing executive compensation for the fiscal years ending December 31, 2022, 2023, and 2024. Th
ALX Oncology Holdings Inc. Announces 2024 Annual Meeting of Stockholders — Apr 22, 2024 Risk: low
ALX ONCOLOGY HOLDINGS INC (ALXO) filed a Proxy Statement (DEF 14A) with the SEC on April 22, 2024. ALX Oncology Holdings Inc. will hold its 2024 Annual Meeting

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX